A randomized, multicenter, parallel-group, Phase III study to compare the
efficacy of arfolitixorin versus leucovorin in combination with 5-fluorouracil,
oxaliplatin, and bevacizumab in patients with advanced colorectal cancer
** For Eligibility information, please click on the "Look up trial at NIH" link above **
Other eligibility criteria may apply.
Other exclusion criteria may apply.